Cancer Biology

Discussions of New Developments and Updates

Skip to content

Home
About
Topics
SHU Department of Biology

Tag Archives: Akt1

Rexahn – 3 Novel Cancer Products in Development

I attended the Rexahn presentation at the Biotech Showcase on January 12-14, 2015. The company has 3 novel anti-cancer products in the clinic. Continue reading →

This entry was posted in Cell Cycle, Oncogenes, Signal Transduction and tagged Afinitor, Akt/PKB, Akt1, Archexin, beta-catenin, Cyclin D, DNA methyltransferase, everolimus, mTOR, p68, Rexahn, RX-3117, Supinoxin, UCK2, uridine-cytidine kinase-2 on January 21, 2015 by Joseph Gulfo.

Search for:

This blog is designed to provide updates in developments in cancer biology and engage in discussions about new findings in the field.

Sponsored by the Department of Biology, Seton Hall University.

@josephgulfo

[fts_twitter twitter_name=@josephgulfo tweets_count=6 cover_photo=no stats_bar=no show_retweets=no show_replies=no]

Proudly powered by WordPress

Pin It on Pinterest